Stay updated with breaking news from Thyroid Eye. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- Data presented at ENDO 2022 indicates low rates of hyperglycemic events were easily controlled, did not cause treatment disruption and were most often seen in patients with pre-existing diabetes
-- Data presented at ENDO 2022 indicates low rates of hyperglycemic events were easily controlled, did not cause treatment disruption and were most often seen in patients with pre-existing diabetes ---- A separate poster presentation examined response to TEPEZZA in patients who were mildly hypothyroid and found outc...
Investegate announcements from Zenas BioPharma, Zenas BioPharma Submits Investigational New Drug Application in China for ZB001 for the Treatment of Thyroid Eye Disease
Viridian Therapeutics, Inc. (NASDAQ:NASDAQ:VRDN) Q1 2022 Earnings Conference Call May 12, 2022, 16:30 ET Company Participants John Jordan - VP, Investor Relations and Corporate...
(BPT) - Meet Franka – a 74-year-old retired high school teacher who enjoys volunteering, teaching in her retirement community, and exploring Arizona’s local art scene. But a few years ago,